CRISPR-Based Sickle Cell Treatment | Pain Tolerance From Neanderthals

If given final approval by the FDA, this sickle-cell treatment would be the first to use gene-editing CRISPR technology on humans. Also, gene variants inherited from Neanderthals can impact pain tolerance in modern humans.